Login

Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer 00:10:00

Share On Facebook Share On Twitter

Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Thomas Wynn, Managing Director at MacKay Shields, predicts that a rise in rates will lead to increased volatility, impacting convertibles.|Naïm Abou-Jaoudé currently serves as Chairman and Interim CEO of MacKay Shields and is the Chief Executive Officer o
00:10:00
Unlock business potential with CMG Cloud, offering scalable solutions, latest software releases, and secure global access to enhance project delivery and productivity.|Pramod Jain is the CEO of Computer Modelling Group
00:10:00
Unlocking Mongolia's High-Grade Gold Deposits: A Path to Development
00:10:00
Dr. Bülent Dal Discusses OBASE's Public Offering Plans | Dr. Bülent Dal, CEO, Obase Bilgisayar ve Danışmanlık Hizmetleri.
00:10:00
Is It Time for a Financial Advisor? Key Factors with James Conole | James Conole - CFP®
00:10:00
Sean Roosen Discusses Ascot Development and Strategic Vision in Mining
00:10:00
Breaking Barriers, Building Empires: The Untold Story of Women in VC|Adina Davis,Principal,BoxGroup
00:10:00
Capital Raise Success and Expansion Plans: Insights from a Leading Public Mexican Issuer | Jorge Avalos Carpinteyro, CEO, Fibra Mty SAPI de CV.
00:10:00
AVACTA's Chief Scientific Officer, Dr. Fiona McLaughlin | Alastair Smith, CEO, AVACTA THERAPEUTICS.
00:10:00
Hamilton Lane Co-CEO Erik Hirsch discusses the future of the Federal Reserve and the current rate hiking cycle on 'Fast Money.'
00:10:00
Maximizing Business Deductions in 2018: Tax Strategies with Qualitax | Sarah Mitchell - Head of Business Taxation, Qualitax
00:10:00
Navigating the Intersection of Politics and Medicine: Insights from a Health Ministry Veteran | Mr. Chi-Hsien Chan, CEO, Adimmune Corp .

© 2017 - Neuhu+